Categories: News

Camber Collective Announces Partnership with Pitchspace, a New Platform Focused on Delivering Enterprise Growth Via Startup Partnerships

SAN FRANCISCO, Jan. 18, 2022 /PRNewswire-PRWeb/ — Camber Collective™ (“Camber”) today announced a partnership with Pitchspace™, a new model focused on improving the effectiveness of partnerships between early-stage startups and established organizations in the healthcare, technology, and social sectors.

Through the Pitchspace model, established organizations and high potential startups will be brought together through a streamlined intake, evaluation and implementation process to align mutual growth objectives. Through the process, larger organizations will be able to unlock new growth opportunities in a scalable, repeatable, and de-risked way, tapping into the growth potential of high potential early-stage companies. At the same time, startups partnering with Pitchspace will gain access to transformative collaborations with large organizations, as well as tools and ongoing implementation support to successfully execute and scale pilot and enterprise-wide collaborations.

“We are in a moment where digital transformation in US healthcare is radically accelerating and digital health company valuations are skyrocketing, yet common points of friction and failure to implementing and scaling up partnerships continue to limit the impact these innovations have on the lives of patients. This partnership brings together and builds upon our mutual experience and lessons-learned working at the intersection of the startup and enterprise healthcare ecosystems over the past 20 years, crafting a unique but practical model that we are confident will deliver unparalleled value and results” said Matt Holman, Partner at Camber.

Mr. Edell is a leader in enterprise-startup partnerships, having successfully scaled emerging companies as an entrepreneur, investor, and strategy consulting partner. Chris was previously a Managing Director at CCI, which runs roundtable meetings for CEOs, Board Chairs and C-Suite teams. Chris was previously CEO and co-founder of Elevar, a consultancy that pioneered the ‘Reverse Pitch’, giving large companies the opportunity to pose business challenges to startups and partner with winners via paid pilots. Clients included many large US healthcare payers, providers, and technology companies.

“Entrepreneurs thrive on discovering new opportunities and turning them into successful business models. Large enterprises thrive at taking a proven model and scaling it into a defensible industry moat. Each party has a unique capability to augment the other to achieve their mutual growth objectives,” said Mr. Edell. “With the right resources, experience, relationships, and implementation support, Pitchspace’s partnership with Camber Collective will give enterprise clients and startups the tools, and best practices to bridge their unique capabilities together.”

Media Contact

Matt Holman, Camber Collective, LLC, 1 415-238-9097, matt@cambercollective.com

Christopher Edell, Pitchspace, 617-384-3035, chris@pitchspace.io

 

SOURCE Camber Collective, LLC

Staff

Recent Posts

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

3 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

4 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

4 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

5 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

7 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

7 hours ago